Sign in
8-K

Current Report

Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-18-207631

Shareholder vote results

  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading d622996d8k.htm…